According to Lieyunwang, Chengdu Corui Technology Co., LTD (Corui Technology) announced that it has completed the Pre-A round financing of 10 million yuan from Jiangning Science and Technology Venture Capital.
As an enterprise of domestic scientific analysis instruments that develops rapidly, Corui Technology focuses on the domestic alternative market of chromatographs in China. In July 2018, Corui Technology closed on angel round financing from Future Capital.
Corui Technology was founded in August 2016. Its UHPLC GEMINI series is the first independently developed ultra-high-performance liquid chromatographs in China. Corui currently has 13 software copyrights, 12 patents, and another 5 invention patents in the substantive examination stage.
"With this fund, Corui will quickly build a sales network in east and south China, and accelerate the commercialization of the new product--blood concentration detector based on two-dimensional liquid chromatography and the development of related methods," said Wang Penghui, the CTO of Corui Technology.
Future Capital believes that China relies heavily on the import of liquid chromatography. The import equipment price is more than 700,000 yuan, while the domestic equipment is mostly low-end and low-priced products with the price below 100,000 yuan. That is to say, there is a huge domestic alternative market for chromatographs in China. It has been verified that the performance of the ultra-liquid chromatography instruments produced by Corui can reach the top of imported instruments, and provide better services, such as short delivery time, fast response to maintenance and so on.
About Jiangning Science and Technology Venture Capital
Nanjing Jiangning Science and Technology Venture Capital Group Co., LTD. (Jiangning Science and Technology Venture Capital) was registered on August 29, 2011, with the registered capital of 200 million yuan. The company is directly controlled by the People's Government of Jiangning District, mainly for small and medium enterprises to provide debt and equity financing, business consulting and services such as industry investment.